Het regionale nierkanker-MDO: nuttig of niet?

Marjolein J.E. Reichert; Paul C.M.S. Verhagen; Marit J. Yska; Ilse R. van den Berg

doi:10.1007/s13629-024-00449-x

Het regionale nierkanker-MDO: nuttig of niet?

Translated title of the contribution: The regional multidisciplinary kidney cancer-meeting: is it useful?

Marjolein J.E. Reichert^*
, Paul C.M.S. Verhagen
, Marit J. Yska
, Ilse R. van den Berg

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Article › Academic › peer-review

16 Downloads (Pure)

Abstract

The incidence of kidney cancer is rising. Patients with (suspected) kidney cancer in the four participating hospitals in Rotterdam and the surrounding area are discussed in a multidisciplinary team meeting (MDM). In 2020 a total of 252 patients from urology departments were discussed in this meeting. Discussion at this meeting led to a change in the treatment plan in 12% of the cases. The main reason for changing the intended treatment was uncertainty about the nature of the kidney abnormality. The MDM advice was executed in 95% of the cases. The main reasons not to follow the MDM-advice were comorbidity or patient preference. 11% of the treated lesions turned out to be benign. Discussion of a case in the kidney cancer-MDM has an important influence on the choice for a treatment option for patients with (suspected) kidney cancer.

Translated title of the contribution	The regional multidisciplinary kidney cancer-meeting: is it useful?
Original language	Dutch
Pages (from-to)	64-68
Number of pages	5
Journal	Tijdschrift voor Urologie
Volume	15
Issue number	4
DOIs	https://doi.org/10.1007/s13629-024-00449-x
Publication status	Published - 5 Nov 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s13629-024-00449-xLicence: CC BY

Het regionale nierkanker-MDOFinal published version, 214 KBLicence: CC BY

Cite this

@article{f43e24aa8949426991b4ddb0b01ca877,

title = "Het regionale nierkanker-MDO: nuttig of niet?",

abstract = "The incidence of kidney cancer is rising. Patients with (suspected) kidney cancer in the four participating hospitals in Rotterdam and the surrounding area are discussed in a multidisciplinary team meeting (MDM). In 2020 a total of 252 patients from urology departments were discussed in this meeting. Discussion at this meeting led to a change in the treatment plan in 12\% of the cases. The main reason for changing the intended treatment was uncertainty about the nature of the kidney abnormality. The MDM advice was executed in 95\% of the cases. The main reasons not to follow the MDM-advice were comorbidity or patient preference. 11\% of the treated lesions turned out to be benign. Discussion of a case in the kidney cancer-MDM has an important influence on the choice for a treatment option for patients with (suspected) kidney cancer.",

author = "Reichert, \{Marjolein J.E.\} and Verhagen, \{Paul C.M.S.\} and Yska, \{Marit J.\} and \{van den Berg\}, \{Ilse R.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2025",

month = nov,

day = "5",

doi = "10.1007/s13629-024-00449-x",

language = "Dutch",

volume = "15",

pages = "64--68",

journal = "Tijdschrift voor Urologie",

issn = "2211-3037",

publisher = "Springer Science+Business Media",

number = "4",

}

TY - JOUR

T1 - Het regionale nierkanker-MDO

T2 - nuttig of niet?

AU - Reichert, Marjolein J.E.

AU - Verhagen, Paul C.M.S.

AU - Yska, Marit J.

AU - van den Berg, Ilse R.

PY - 2025/11/5

Y1 - 2025/11/5

N2 - The incidence of kidney cancer is rising. Patients with (suspected) kidney cancer in the four participating hospitals in Rotterdam and the surrounding area are discussed in a multidisciplinary team meeting (MDM). In 2020 a total of 252 patients from urology departments were discussed in this meeting. Discussion at this meeting led to a change in the treatment plan in 12% of the cases. The main reason for changing the intended treatment was uncertainty about the nature of the kidney abnormality. The MDM advice was executed in 95% of the cases. The main reasons not to follow the MDM-advice were comorbidity or patient preference. 11% of the treated lesions turned out to be benign. Discussion of a case in the kidney cancer-MDM has an important influence on the choice for a treatment option for patients with (suspected) kidney cancer.

AB - The incidence of kidney cancer is rising. Patients with (suspected) kidney cancer in the four participating hospitals in Rotterdam and the surrounding area are discussed in a multidisciplinary team meeting (MDM). In 2020 a total of 252 patients from urology departments were discussed in this meeting. Discussion at this meeting led to a change in the treatment plan in 12% of the cases. The main reason for changing the intended treatment was uncertainty about the nature of the kidney abnormality. The MDM advice was executed in 95% of the cases. The main reasons not to follow the MDM-advice were comorbidity or patient preference. 11% of the treated lesions turned out to be benign. Discussion of a case in the kidney cancer-MDM has an important influence on the choice for a treatment option for patients with (suspected) kidney cancer.

UR - https://www.scopus.com/pages/publications/85208455946

U2 - 10.1007/s13629-024-00449-x

DO - 10.1007/s13629-024-00449-x

M3 - Article

AN - SCOPUS:85208455946

SN - 2211-3037

VL - 15

SP - 64

EP - 68

JO - Tijdschrift voor Urologie

JF - Tijdschrift voor Urologie

IS - 4

ER -

Het regionale nierkanker-MDO: nuttig of niet?

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this